Biology Reference
In-Depth Information
Moriuchi H, et al. 1997. Cloning and analysis of the promoter region of CCR5, a coreceptor for
HIV-1 entry. J Immunol 159: 5441±5449.
Mummidi S, et al. 1998. Genealogy of the CCR5 locus and chemokine system gene variants asso-
ciated with altered rates of HIV-1 disease progression. Nat Med 4: 786±793.
Murdoch C, Finn A. 2000. Chemokine receptors and their role in in¯ammation and infectious dis-
ease. Blood 95: 3032±3043.
Ostrowski MA, et al. 1998. Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-
infected and uninfected individuals. J Immunol 161: 3195±3201.
Ostrowski MA, et al. 1999. Both memory and CD45RA/CD62L naive CD4 T cells are in-
fected in human immunode®ciency virus type 1-infected individuals. J Virol 73: 6430±6435.
Park IW, et al. 1999. Expression and utilization of co-receptors in HIV and simian immuno-
de®ciency virus infection of megakaryocytes. AIDS 13: 2023±2032.
Platt EJ, et al. 1998. E¨ects of CCR5 and CD4 cell surface concentrations on infections by macro-
phagetropic isolates of human immunode®ciency virus type 1. J Virol 72: 2855±2864.
Poncelet F, et al. 1996. Quantitation of hematopoietic cell antigens in ¯ow cytometry. Eur J Histo-
chem 1: 15±32.
Rana S, et al. 1997. Role of CCR5 in infection of primary macrophages and lymphocytes by
macrophage-tropic strains of human immunode®ciency virus: resistance to patient-derived and
prototype isolates resulting from the delta ccr5 mutation. J Virol 71: 3219±3227.
Reeves JD, et al. 1997. CD4-independent infection by HIV-2 (ROD/B): use of the 7-transmem-
brane receptors CXCR-4, CCR-3, and V28 for entry. Virology 231: 130±134.
Reynes J, et al. 2000. CD4
T Cell surface CCR5 density and virus load in persons infected with
human immunode®ciency virus type I. J Inf Dis 182: 1285±1286.
Rucker J, et al. 1997. Utilization of chemokine receptors, orphan receptors, and herpesvirus-
encoded receptors by diverse human and simian immunode®ciency viruses. J Virol 71: 8999±
9007.
Samson M, et al. 1998. ChemR23, a putative chemoattractant receptor, is expressed in dendritic
cells and is a coreceptor for SIV and some primary HIV-1 strains. Eur J Immunol 28: 1689±
1700.
Schramm B, et al. 2000. Viral entry through CXCR4 is a pathogenic factor and therapeutic target in
human immunode®ciency virus type 1 disease. J Virol 74: 184±192.
Sharron M, et al. 2000. Expression and coreceptor activity of STRL33/Bonzo on primary periph-
eral blood lymphocytes. Blood 96: 41±49.
Shieh JT, et al. 1998. Chemokine receptor utilization by human immunode®ciency virus type 1
isolates that replicate in microglia. J Virol 72: 4243±4249.
Shimizu N, et al. 2000. A putative G protein coupled receptor, RDC1, is a novel coreceptor for
human and simian immunode®ciency viruses. J Virol 74: 619±626.
van Rij RP, et al. 1998. The role of a stromal cell-derived factor-1 chemokine gene variant in the
clinical course of HIV-1 infection. AIDS 12: F85±F90.
van Rij RP, et al. 1999. Reduced prevalence of the CCR5 delta32 heterozygous genotype in human
immunode®ciency virus-infected individuals with AIDS dementia complex. J Infect Dis 180:
854±857.
Walli R, et al. 1998. HIV-1-infected long-term slow progressors heterozygous for delta32-CCR5
show signi®cantly lower plasma viral load than wild-type slow progressors. J Acquir Immune
De®c Syndr Hum Retrovirol 18: 229±233.
Ward SG, Westwick J. 1998. Chemokines: understanding their role in T-lymphocyte biology. Bio-
chem J 333: 457±470.
Ward SG, et al. 1998. Chemokines and T lymphocytes: more than an attraction. Immunity 9: 1±
11.
